What changed in the research briefs, and why. Corrections are listed here
in full rather than quietly fixed, because a reader who acted on the old wording deserves
to know it moved.
On the reading list
The last literature check, on 15 November 2026, found 20 papers on SSPE and measles antivirals that this site does not yet cite. None has been read or reviewed, so none is on a page yet.
We published the full source list behind the SSPE research — 85 documents, each tagged by whether we read the full paper or could only get the abstract. 51 were read in full.
The tag is the point. Working through this literature we kept finding figures that are quoted everywhere but trace back to an abstract, to a review citing a review, or to nothing retrievable at all. A claim resting on an abstract should not be repeated until someone has the document. [See the source map](evidence/sspe.html)
We had written that one Peshawar clinic confirmed 90 SSPE cases "in the first nine months of 2026". The original report says 90 confirmed cases in the year to September 2026 — twelve months, not nine. Corrected everywhere it appeared.
The number is still striking: around ten cases a month at a single centre, against an international registry that captured nine patients across four countries in three years.
Correction: what the new measles antiviral can and cannot show
We had said the experimental oral measles drug GHP-88310 has "no brain data". That was too strong. The paper does report brain tissue drug concentrations, from a single-dose study in cotton rats. What it has no data on is whether the drug does anything to an infection inside the brain — there is no CNS infection model anywhere in the programme.
The distinction matters for SSPE, where getting into the brain is only the first problem.
Every week we now ask Europe PMC what has been published on SSPE and on measles antivirals, and compare it against what this site already cites. The first run looked back 120 days and found 18 papers we had not seen, including a study of SSPE following measles outbreaks in the Philippines and new antibodies against the measles fusion protein.
Nothing found this way goes straight onto the site. A paper the check finds has not been read by anyone yet. It joins a reading list, and reaches a page only after Dr. Sana has read it.
